Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
Breast Cancer Research and Treatment
|
February 27, 2023
Effective combination treatments for breast cancer inhibition by FOXM1 inhibitors with other targeted cancer drugs
Valeria Sanabria Guillen, Yvonne Ziegler, Chirag Gopinath, et al.
Breast Cancer Research and Treatment
|
April 12, 2020
Suppression of breast cancer metastasis and extension of survival by a new antiestrogen in a preclinical model driven by mutant estrogen receptors
Mary J Laws, Yvonne Ziegler, Sayyed Hamed Shahoei, et al.
Journal of Medicinal Chemistry
|
June 29, 2017
Adamantyl Antiestrogens with Novel Side Chains Reveal a Spectrum of Activities in Suppressing Estrogen Receptor Mediated Activities in Breast Cancer Cells
Jian Min, Valeria Sanabria Guillen, Abhishek Sharma, et al.
ACS Pharmacology & Translational Science
|
August 14, 2025
Benzestrol Isomer Stereochemistry Determines the Distinct Estrogenic Activities and Conformations of the Eight Isomers When Bound to Estrogen Receptor α
Yingwei Hou, Jerome C Nwachukwu, Kathryn Carlson, et al.
Biorxiv : the Preprint Server for Biology
|
April 22, 2024
Asymmetric Allostery in Estrogen Receptor-α Homodimers Drives Responses to the Ensemble of Estrogens in the Hormonal Milieu
Charles K Min, Jerome C Nwachukwu, Yingwei Hou, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 3, 2024
Asymmetric allostery in estrogen receptor-α homodimers drives responses to the ensemble of estrogens in the hormonal milieu
Charles K Min, Jerome C Nwachukwu, Yingwei Hou, et al.
Cancer Research
|
September 15, 2017
Structurally Novel Antiestrogens Elicit Differential Responses from Constitutively Active Mutant Estrogen Receptors in Breast Cancer Cells and Tumors
Yuechao Zhao, Mary J Laws, Valeria Sanabria Guillen, et al.
NPJ Breast Cancer
|
December 10, 2019
Suppression of FOXM1 activities and breast cancer growth in vitro and in vivo by a new class of compounds
Yvonne Ziegler, Mary J Laws, Valeria Sanabria Guillen, et al.
Molecular Cancer Research : MCR
|
March 8, 2022
Targeting Metabolic Adaptations in the Breast Cancer-Liver Metastatic Niche Using Dietary Approaches to Improve Endocrine Therapy Efficacy
Qianying Zuo, Ayca Nazli Mogol, Yu-Jeh Liu, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 28, 2021
Dual-mechanism estrogen receptor inhibitors
Jian Min, Jerome C Nwachukwu, Charles K Min, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
Breast Cancer Research and Treatment
|
February 27, 2023
Effective combination treatments for breast cancer inhibition by FOXM1 inhibitors with other targeted cancer drugs
Valeria Sanabria Guillen, Yvonne Ziegler, Chirag Gopinath, et al.
Breast Cancer Research and Treatment
|
April 12, 2020
Suppression of breast cancer metastasis and extension of survival by a new antiestrogen in a preclinical model driven by mutant estrogen receptors
Mary J Laws, Yvonne Ziegler, Sayyed Hamed Shahoei, et al.
Journal of Medicinal Chemistry
|
June 29, 2017
Adamantyl Antiestrogens with Novel Side Chains Reveal a Spectrum of Activities in Suppressing Estrogen Receptor Mediated Activities in Breast Cancer Cells
Jian Min, Valeria Sanabria Guillen, Abhishek Sharma, et al.
ACS Pharmacology & Translational Science
|
August 14, 2025
Benzestrol Isomer Stereochemistry Determines the Distinct Estrogenic Activities and Conformations of the Eight Isomers When Bound to Estrogen Receptor α
Yingwei Hou, Jerome C Nwachukwu, Kathryn Carlson, et al.
Biorxiv : the Preprint Server for Biology
|
April 22, 2024
Asymmetric Allostery in Estrogen Receptor-α Homodimers Drives Responses to the Ensemble of Estrogens in the Hormonal Milieu
Charles K Min, Jerome C Nwachukwu, Yingwei Hou, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 3, 2024
Asymmetric allostery in estrogen receptor-α homodimers drives responses to the ensemble of estrogens in the hormonal milieu
Charles K Min, Jerome C Nwachukwu, Yingwei Hou, et al.
Cancer Research
|
September 15, 2017
Structurally Novel Antiestrogens Elicit Differential Responses from Constitutively Active Mutant Estrogen Receptors in Breast Cancer Cells and Tumors
Yuechao Zhao, Mary J Laws, Valeria Sanabria Guillen, et al.
NPJ Breast Cancer
|
December 10, 2019
Suppression of FOXM1 activities and breast cancer growth in vitro and in vivo by a new class of compounds
Yvonne Ziegler, Mary J Laws, Valeria Sanabria Guillen, et al.
Molecular Cancer Research : MCR
|
March 8, 2022
Targeting Metabolic Adaptations in the Breast Cancer-Liver Metastatic Niche Using Dietary Approaches to Improve Endocrine Therapy Efficacy
Qianying Zuo, Ayca Nazli Mogol, Yu-Jeh Liu, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 28, 2021
Dual-mechanism estrogen receptor inhibitors
Jian Min, Jerome C Nwachukwu, Charles K Min, et al.
Page
of 2